These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18855873)

  • 1. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit.
    Hadjivassiliou M; Alder SJ; Van Beek EJ; Hanney MB; Lorenz E; Rao DG; Sharrack B; Tindale WB
    Acta Neurol Scand; 2009 Mar; 119(3):186-93. PubMed ID: 18855873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
    Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [(18)F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome].
    García Vicente AM; Vega Caicedo CH; Mondéjar Solís R; de Ayala Fernández JÁ; Garrido Robles JA; Pena Pardo FJ; Muñoz Pasadas M; Del Saz Saucedo P; Jiménez Londoño GA; León Martín A; Soriano Castrejón Á
    Rev Esp Med Nucl Imagen Mol; 2015; 34(4):236-43. PubMed ID: 25864422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
    Patel RR; Subramaniam RM; Mandrekar JN; Hammack JE; Lowe VJ; Jett JR
    Mayo Clin Proc; 2008 Aug; 83(8):917-22. PubMed ID: 18674476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.
    Matsuhisa A; Toriihara A; Kubota K; Makino T; Mizusawa H; Shibuya H
    Clin Nucl Med; 2012 Jan; 37(1):39-43. PubMed ID: 22157026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Workup of Suspected Classical Paraneoplastic Neurological Syndromes: A Systematic Review and Retrospective Analysis of
    Sundermann B; Schröder JB; Warnecke T; Heindel W; Schäfers M; Weckesser M; Buerke B
    Acad Radiol; 2017 Oct; 24(10):1195-1202. PubMed ID: 28551401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
    Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
    Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients.
    Kristensen SB; Hess S; Petersen H; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2056-63. PubMed ID: 26194717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis.
    Bannas P; Weber C; Derlin T; Lambert J; Leypoldt F; Adam G; Mester J; Klutmann S
    Eur Radiol; 2010 Apr; 20(4):923-30. PubMed ID: 19789881
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Harlos C; Metser U; Poon R; MacCrostie P; Mason W
    Curr Oncol; 2019 Aug; 26(4):e458-e465. PubMed ID: 31548813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification.
    Pena Pardo FJ; García Vicente AM; Amo-Salas M; López-Fidalgo JF; Garrido Robles JA; de Ayala Fernández JÁ; Del Saz Saucedo P; Muñoz Pasadas M; Soriano Castrejón A
    Clin Transl Oncol; 2017 Jan; 19(1):111-118. PubMed ID: 27139696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    García Vicente AM; Delgado-Bolton RC; Amo-Salas M; López-Fidalgo J; Caresia Aróztegui AP; García Garzón JR; Orcajo Rincón J; García Velloso MJ; de Arcocha Torres M; Alvárez Ruíz S;
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1575-1587. PubMed ID: 28550611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body computed tomography as first-line imaging procedure to exclude cancer in patients with neurological suspicion of paraneoplastic syndromes: shall clinical practice adhere to recommendations?
    Parillo M; Quattrocchi CC; Pilato F; Di Lazzaro V; Beomonte Zobel B
    Radiography (Lond); 2023 Jan; 29(1):8-13. PubMed ID: 36179410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
    Subramaniam RM; Shields AF; Sachedina A; Hanna L; Duan F; Siegel BA; Hillner BE
    Oncologist; 2016 Sep; 21(9):1079-84. PubMed ID: 27401896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on paraneoplastic neurological syndromes.
    Didelot A; Honnorat J
    Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic autoantibody panels: sensitivity and specificity, a retrospective cohort.
    Albadareen R; Gronseth G; Goeden M; Sharrock M; Lechtenberg C; Wang Y
    Int J Neurosci; 2017 Jun; 127(6):531-538. PubMed ID: 27356679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes.
    Clapp AJ; Hunt CH; Johnson GB; Peller PJ
    Clin Nucl Med; 2013 Apr; 38(4):241-7. PubMed ID: 23429394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre.
    Vaidyanathan S; Pennington C; Ng CY; Poon FW; Han S
    Nucl Med Commun; 2012 Aug; 33(8):872-80. PubMed ID: 22669052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.